Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer

Hepato-Gastroenterology

Volumn 61, Issue 136, 2014, Pages 2236-2240

  Shibutani, Masatsune ^a   Maeda, Kiyoshi ^a   Nagahara, Hisashi ^a   Ohtani, Hiroshi ^a   Sugano, Kenji ^a   Ikeya, Tetsuro ^a   Kimura, Kenjiro ^a   Amano, Ryosuke ^a   Kubo, Naoshi ^a   Tanaka, Hiroaki ^a   Muguruma, Kazuya ^a   Ohira, Masaichi ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C reactive protein; Colorectal cancer; Prognosis; Systemic inflammatoi y response

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; BLOOD; COLORECTAL TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; AGED; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 84921795501     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge13770     Document Type: Article

References (21)

1. Sobin LH, Gospodarowicz MK and Wittekind C: UICC TNM Classification of Malignant Tumors Seventh edition New York Wiley-Liss, 2009.
2. Laurie JA, Moertel CG, Fleming T.R., et al.: Surgical ad]uvant therapy of large-bowel carcinoma an evaluation of levamisole and the combination of levamisole and fluorouracil The North Central Cancer Treatment Group and the Mayo Clinic. J Clm Oncol 1989, 7-1447-1456
3. Ishizuka M, Nagata H, Takagi K., et al.: Inflammation-based prognostic system predicts survival after surgery for stage IV colorectal cancer Am J Surg 2013, 205 22-29
4. McLeod HL, Murray GI: Tumour markers of prognosis in colorectal cancer. Br J Cancer 1999, 79 191-203.
5. Nakagoe T, Sawai T, Tsuji T., et al.: Preoperative serum level of CA19-9 predicts recurrence after curative surgery in nodenegative colorectal cancer patients. Hepatogastroenterology 2003, 50 696-699
6. Park IJ, Choi GS, Lim K.H., et al.: Serum carcrnoembryomc antigen monitoring after curative resection for colorectal cancer clinical significance of the preoperative level Ann Surg Oncol 2009; 16-3087-3093.
7. Takagawa R, Fujii S, Ohta M., et al.: Preoperative serum carcinoembryomc antigen level as a predictive factor of recurrence after curative resection of colorectal cancer Ann Surg Oncol 2008; 15-3433-3439
8. Hara M, Kanemitsu Y, Hirai T., et al.: Negative serum carcinoembryomc antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer analysis with likelihood ratio and posttest probability in a followup study Dis Colon Rectum 2008; 51. 1675-1680
9. Hara M, Sato M, Takahashi H., et al.: Does serum carcinoembryomc antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III J Surg Oncol 2010, 102. 154-157
10. Chaturvedi AK, Caporaso NE, Katki H.A., et al.: C-reactive protein and risk of lung cancer J Clin Oncol 2010, 28:2719-2726
11. Koike Y, Miki C, Okugawa Y., et al.: Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer J Surg Oncol 2008; 98-540-544
12. Nozoe T, Iguchi T, Adachi E., et al.: Preoperative elevation of serum C-reactive protein as an independent prognostic indicator tor gastric cancer Surg Today 2011, 41. 510-513
13. Nozoe T, Mori E, Takahashi I., et al.: Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma Surg Today 2008; 38. 597-602.
14. Tolyama Y, Miki C, Inoue Y., et al.: Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer Exp Ther Med 2011, 2:95-101
15. McMillan DC, Crozier JE, Canna K, et al.: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer Int J Colorectal Dis 2007, 22. 881-886
16. Crumley AB, McMillan DC, McKernan M, et al.: An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer Br J Cancer 2006, 94:1568-1571.
17. Zimmerman MA, Selzman CH, Cothren C, et al.: Diagnostic implications of C-reactive protein. Arch Surg 2003, 138. 220-224
18. Mantovani A, Allavena P, Sica A., et al.: Cancer-related inflammation Nature 2008, 454. 436-444
19. Heikkila K, Ebrahim S, Lawlor DA: A systematic review of the association between circulating concentrations of C reactive protein and cancer J Epidemiol Community Health 2007, 61 824-833.
20. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002, 420 860-867.
21. Japanese Society for Cancer of the Colon, Rectum General rules for clinical and pathological studies on cancer of the colon, rectum and anus Seventh edition Tokyo Kanehara, 2006